Star Health and Allied Insurance shares dropped 3.29% to ₹518.60 on the NSE as of 9:15 am following the release of its Q2 FY25 results, which revealed substantial underwriting losses:
- Underwriting Loss: Increased 1.5 times YoY to ₹195 crore, up from ₹78 crore last year, surpassing brokerage estimates.
- Combined Ratio (CoR): Rose by 379 basis points to 102.99%, compared to 99.2% YoY, reflecting intensified operational losses.
The elevated underwriting loss and combined ratio indicate greater-than-expected strain on Star Health’s profitability, causing investor concerns and impacting stock performance.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
TOPICS:
Star Health